This content is machine translated Lung cancer with EGFR mutation New perspectives in first-line therapy At this year’s IASLC World Conference on Lung Cancer (WCLC 2025) in Barcelona, a poster on the FLAURA2 study was presented, which presented new data on combination therapy with osimertinib...…
